ELV - Elevance Health
365.96
| Index: | S&P 500 | P/E: | 13.34 | EPS (ttm): | 27.43 | Insider Own: | 0.21% | Shs Outstand: | 231.93M | Perf Week: | -4.05% |
| Market Cap: | 84.75B | Forward P/E: | 10.48 | EPS next Y: | 34.91 | Insider Trans: | -8.03% | Shs Float: | 231.44M | Perf Month: | -7.93% |
| Income(ttm): | 6.42B | PEG: | 1.48 | EPS next Q: | 3.98 | Inst Own: | 90.41% | Short Float: | 1.22% | Perf Quarter: | -31.46% |
| Revenue(ttm): | 174.01B | P/S: | 0.49 | EPS this Y: | 0.12% | Inst Trans: | -1.47% | Short Ratio: | 1.47 | Perf Half Y: | -32.44% |
| Book/sh: | 188.74 | P/B: | 1.94 | EPS next Y: | 5.21% | ROA: | 5.65% | Short Interest: | 2.82M | Perf Year: | -20.31% |
| Cash/sh: | - | P/C: | - | EPS next 5Y: | 9.01% | ROE: | 15.62% | 52W Range: | 362.21 - 567.26 | Perf YTD: | -22.39% |
| Dividend Est.: | 6.33 (1.73%) | P/FCF: | 97.31 | EPS past 5Y: | 12.18% | ROI: | 9.37% | 52W High: | -35.49% | Beta: | 0.85 |
| Dividend TTM: | 6.52 (1.78%) | Quick Ratio: | - | Sales past 5Y: | 13.24% | Gross Margin: | - | 52W Low: | 1.04% | ATR (14): | 10.29 |
| Dividend Ex-Date: | Dec 05, 2024 | Current Ratio: | 1.50 | EPS Y/Y TTM: | 7.55% | Oper. Margin: | 5.29% | RSI (14): | 28.86 | Volatility: | 2.68% 2.51% |
| Employees: | 104900 | Debt/Eq: | 0.62 | Sales Y/Y TTM: | 3.20% | Profit Margin: | 3.69% | Recom: | 1.71 | Target Price: | 499.39 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.56 | EPS Q/Q: | -20.03% | Payout: | 23.47% | Rel Volume: | 1.79 | Prev Close: | 366.48 |
| Sales Surprise: | 2.88% | EPS Surprise: | -13.33% | Sales Q/Q: | 5.36% | Earnings: | Oct 17 BMO | Avg Volume: | 1.92M | Price: | 365.96 |
| SMA20: | -5.98% | SMA50: | -11.09% | SMA200: | -26.61% | Undervalued: 36.46% | Volume: | 3,438,136 | Change: | -0.14% | |
Graham Classic formula value: 653.21
(P/E=8 * 1g) Min value: 418.97
(current P/E * 2g) Max value: 772.43
Average value: 614.87
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.